Denosumab discontinuation

Papers on denosumab discontinuation

3 papers

Monday, March 16

Frontiers in EndocrinologyMar 16

Modeling rebound bone loss following denosumab discontinuation and sequential zoledronate therapy in TgRANKL osteoporotic mice

Experiments in miceDenosumab

Monday, August 14

Bone ReportsAug 14

Trabecular bone deterioration in a postmenopausal female suffering multiple spontaneous vertebral fractures due to a delayed denosumab injection - A post-treatment re-initiation bone biopsy-based case study

Case reportDenosumab

Tuesday, August 24

HSS JournalAug 24

Vertebral Fractures After Denosumab Discontinuation in Breast Cancer Survivors: A Single Institution Experience

Cohort study of 335 peopleDenosumab